Tuesday, November 26, 2024

Popular diabetes and obesity drugs also protect kidneys, study shows

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.

from Top Health News -- ScienceDaily https://ift.tt/Wk0lJXR
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ebola and hantavirus can start like the flu but turn deadly fast

Two dangerous viruses are back in the spotlight, reminding health officials how quickly infectious diseases can become serious threats. Hant...